We rate Healthways (HWAY) a HOLD. Our rating is supported by the company's top-line growth and higher earnings countered by its weak cash and liquidity position. Although the margins and returns are improving, rising expenses along with mounting debt may negatively impact the company's performance in the upcoming quarters.
-- Top-line growth. Healthways Inc.'s Q1 FY09 revenue grew 5.5% to $185.40 million from $175.82 million in the prior year's quarter due to contributions from the commencement of new contracts, increase in the recognition of performance-based fees and growth in the number of self-insured employers on behalf of its health plan customers. Domestic commercial available lives and domestic commercial billed lives advanced 6.3% and 22.5%, respectively.
-- Higher earnings. During Q1 FY09, earnings increased on the back of higher revenue growth. Net income for the quarter swelled 12.5% to $12.58 million or $0.37 per share compared to $11.18 million or $0.30 per share in the prior year's quarter attributed to higher revenue.-- Improving margins and returns. During the quarter, gross profit margin widened 103 basis points to 30.40% from 29.37% and operating margin increased 31 basis points to 14.15% from 13.84%. Moreover, return on assets and return on equity increased 123 basis points and 377 basis points to 6.37% and 15.33% respectively. -- Weak cash and liquidity position. Healthways' cash and cash equivalents plunged 92.0% to $4.35 million from $54.53 million while net operating cash flow declined 15.0% to $21.65 million when compared to the same quarter last year. Moreover, the company has a quick ratio of 0.75 which shows its inability to meet short-term cash requirements.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV